Inventor · disambiguated record
Kevin James Filipski
Also filed as: FILIPSKI KEVIN · FILIPSKI KEVIN J · FILIPSKI KEVIN JAMES
18 granted patents·15 pending applications·89 citations·filing 2002–2025
92Inventor score
Top patents by PatentIndex Score
33 records- 0193US11542270B2BCKDK inhibitorsPFIZER·Filed 2020·Granted Jan 3, 2023·6 cites·18 claims
- 0293US11059833B2BCKDK inhibitorsPFIZER·Filed 2020·Granted Jul 13, 2021·7 cites·23 claims
- 0391US7030141B2Inhibitors of factor Xa and other serine proteases involved in the coagulation cascadeBIGGE CHRISTOPHER FRANKLIN·Filed 2002·Granted Apr 18, 2006·62 cites·83 claims
- 0484US11065249B2Diacylglycerol acyl transferase 2 inhibitorPFIZER·Filed 2020·Granted Jul 20, 2021·1 cites·30 claims
- 0583US11471458B2Diacylglycerol acyl transferase 2 inhibitorPFIZER·Filed 2020·Granted Oct 18, 2022·1 cites·17 claims
- 0680US8889730B2Indole and indazole compounds that activate AMPKPFIZER·Filed 2013·Granted Nov 18, 2014·5 cites·5 claims
- 0778US8507533B2Glucagon receptor modulatorsASPNES GARY ERIK·Filed 2012·Granted Aug 13, 2013·3 cites·5 claims
- 0875US7407974B2Inhibitors of factor Xa and other serine proteases involved in the coagulation cascadePFIZER·Filed 2005·Granted Aug 5, 2008·1 cites·6 claims
- 0972US9056834B2Glucagon receptor modulatorsPFIZER·Filed 2014·Granted Jun 16, 2015·1 cites·10 claims
- 1072US8859591B2Glucagon receptor modulatorsPFIZER·Filed 2013·Granted Oct 14, 2014·1 cites·18 claims
- 1169US9394285B2Indole and indazole compounds that activate AMPKPFIZER·Filed 2013·Granted Jul 19, 2016·1 cites·6 claims
- 1266US9073871B2Glucagon receptor modulatorsPFIZER·Filed 2014·Granted Jul 7, 2015·0 cites·2 claims
- 1365US2024336572A1Substituted indazole propionic acid derivative compounds and uses thereofPFIZER·Filed 2024·Application pending·0 cites
- 1465US2009221546A1Inhibitors of factor xa and other serine proteases involved in the coagulation cascadePFIZER·Filed 2008·Application pending·0 cites
- 1562US9139538B2Quinolinyl glucagon receptor modulatorsPFIZER·Filed 2014·Granted Sep 22, 2015·0 cites·8 claims
- 1662US8933104B2Glucagon receptor modulatorsPFIZER·Filed 2014·Granted Jan 13, 2015·0 cites·10 claims
- 1762US2008287674A1Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation CascadeBIGGE CHRISTOPHER FRANKLIN·Filed 2008·Application pending·0 cites
- 1860US2024366598A1Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereofPFIZER·Filed 2024·Application pending·0 cites
- 1959US2006264626A1INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADEWARNER LAMBERT CO·Filed 2006·Application pending·0 cites
- 2058US9452999B2Glucagon receptor modulatorsPFIZER·Filed 2015·Granted Sep 27, 2016·0 cites·12 claims
- 2157US2016362392A1Glucagon receptor modulatorsPFIZER·Filed 2016·Application pending·0 cites
- 2254US8809342B2Glucagon receptor modulatorsASPNES GARY ERIK·Filed 2011·Granted Aug 19, 2014·0 cites·8 claims
- 2351US2025326741A1Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereofPFIZER·Filed 2025·Application pending·0 cites
- 2451US2015038484A1Indole and indazole compounds that activate ampkPFIZER·Filed 2014·Application pending·0 cites
- 2551US2015266861A1Glucagon Receptor ModulatorsPFIZER·Filed 2015·Application pending·0 cites
- 2650US12466803B2BCKDK inhibitors and/or degradersPFIZER·Filed 2022·Granted Nov 11, 2025·0 cites·16 claims
- 2750US8927577B2Quinolinyl glucagon receptor modulatorsDIDIUK MARY·Filed 2012·Granted Jan 6, 2015·0 cites·13 claims
- 2847US2022363673A15-(Thiophen-2-YL)-1 H-Tetrazole Derivative as BCKDK Inhibitors Useful for Treating Various DiseasesPFIZER·Filed 2020·Application pending·0 cites
- 2947US2015353508A1Quinolinyl glucagon receptor modulatorsPFIZER·Filed 2015·Application pending·0 cites
- 3045US2023405002A1Combinations of diacylglycerol acyltransferase 2 inhibitors and acetyl-coa carboxylase inhibitorPFIZER·Filed 2021·Application pending·0 cites
- 3143US2004167131A1Inhibitors of factor Xa and other serine proteases involved in the coagulation cascadePFIZER·Filed 2003·Application pending·0 cites
- 3241US2025235510A1Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist peptidesPFIZER·Filed 2025·Application pending·0 cites
- 3341US2025235460A1Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compoundsPFIZER·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin James Filipski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →